Respiratory Health Association plays an important role in research. Unfortunately, lung disease research is underfunded, slowing gains in knowledge, diagnosis and treatment progress. RHA actively works to address this by supporting clinical trial studies, participating in research collaborations, and funding innovative lung health research.
Since 1998, RHA has awarded 53 lung health research grants in excess of $3.4 million. Lung cancer research was the focus of 42% of these grants ($1.4M) with asthma grants, awarded from 2002-2012, accounting for 21% of research grants ($1.1M). Other grants (16% or $817,000) supported a variety of studies including those focused on pulmonary hypertension and acute respiratory distress syndrome (ARDS). Learn more about the projects we have funded.
If you’d like to help fund RHA’s research efforts, contact Joel Africk, President and Chief Executive Officer, via email at [email protected] or by phone at (312) 628-0220.